Healthcare Analytics, Population Health Management, Healthcare Big Data

Medical Research

Next-Generation Genomics, Precision Medicine to Top $100B

by Jennifer Bresnick

The markets for next-generation genomic testing tools and precision medicine software and services will be worth more than $100 billion by 2022, according to a new series of market reports, propelled by breakthroughs in cancer care, big data...

Precision Medicine, Population Health Share Strategies and Goals

by Jennifer Bresnick

Any organization that wants to have a hope of functioning smoothly divides its operations into distinct departments, each of which is in charge of a specific process.  Every member of the team contributes to the organization’s ultimate...

Point of Care Diagnostics Usher in Era of Personalized Medicine

by Jennifer Bresnick

Even before the advent of value-based care, healthcare providers have always faced pressure to do more, do it better, and do it faster while using fewer resources and producing high quality results.  As reimbursement changes tighten the...

Cancer Detection Company Gets $900M from Pharma, VC Investors

by Jennifer Bresnick

GRAIL, Inc., a precision medicine and life sciences company aiming to develop new very early detection techniques for cancer, has attracted more than $900 million in investment capital from some of the most well-known names in pharmaceutical...

Are Clinical Trials Diverse Enough to Ensure Patient Safety?

by Thomas Beaton

A new FDA report indicates that clinical trials may not be accurately representing real-world demographic patterns, leading to concerns that new drugs are not being accurately tested for patient safety and effectiveness.  Only 48 percent...

NIH Renames Precision Medicine Cohort, Urges Patient Engagement

by Thomas Beaton

The newly unveiled All of Us Research Program, formally known as the Precision Medicine Initiative (PMI) Cohort, will help the NIH collect diverse patient data and foster patient engagement to support its million-member precision medicine biobank....

NIH Awards $21M to Precision Medicine Epilepsy Collaboration

by Jennifer Bresnick

An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and treatment of epilepsy. The collaboration, spearheaded...

Cancer Mortality Rates See 20% Drop, but Disparities Remain

by Thomas Beaton

Cancer mortality rates have decreased nationally by more than 20 percent since 1980, yet local “hotspots” of disparities remain in certain communities, says an article published in JAMA this month. After reviewing more than 19.5 million...

Gates Foundation Grants $279M to UW Population Health Program

by Jennifer Bresnick

The Bill & Melinda Gates Foundation has committed to invest $279 million in the University of Washington’s Institute for Health Metrics and Evaluation (IHME) to build on the school’s population health management research efforts....

PCORI Offers $200M in Grants for Patient-Centered Research

by Thomas Beaton

Patient-centered research projects are getting a significant financial boost early in the year thanks to the Patient-Centered Outcomes Research Institute (PCORI), which has allocated a total of $200 million for research proposals that compare...

AMIA Advises PCORI on Sharing Big Data for Health Research

by Thomas Beaton

The American Medical Informatics Association (AMIA) has suggested that the Patient-Centered Outcomes Research Institute (PCORI) should adopt new policies that focus on expanding grant opportunities and funding data collection efforts to improve...

Precision Medicine Benefits Pediatric Cancer Care, Study Says

by Thomas Beaton

Investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found that precision medicine can be used to diagnose genetic abnormalities and properly treat patients with pediatric brain cancers. By testing tumor samples,...

Northwell Health Launches Precision Medicine, Cancer Biobank

by Thomas Beaton

Northwell Health and Indivumed are creating a new patient biobank to help expand opportunities for cancer research and the development of precision medicine therapies. In the three-year agreement announced in a press release this week, Northwell...

Cancer Research Orgs Release Big Data for Precision Medicine

by Jennifer Bresnick

The American Association for Cancer Research (AACR) is releasing more than 19,000 de-identified genomic records to further the international research community’s explorations into precision medicine.  The big data dump, which includes...

New Geisinger Med School Has Population Health, Genomics Focus

by Thomas Beaton

To ring in the New Year, Geisinger Health System CEO Dr. David T. Feinberg announced the opening of The Geisinger Commonwealth School of Medicine in Scranton, PA, at 12:01 AM. The school debuts with programs that focus on improving community...

Research Collaboration to Use Big Data for Diabetes Prevention

by Thomas Beaton

In an effort to improve the treatment and understanding of type 2 diabetes in various patient populations, a new collaboration between the Indiana Bioscience Research Institute (IBRI), Eli Lilly and Company, Roche Diagnostics, the Regenstrief...

Precision Medicine, Big Data Partnerships Will Enhance Treatment

by Jennifer Bresnick

The calendar year may be coming to its end, but the nation’s work on precision medicine is just getting started.  Spurred on by the continuing development of big data analytics techniques and pepped up by the landslide passage of the...

Penn Precision Medicine Accelerator Doles Out $525K in Grants

by Jennifer Bresnick

The Penn Center for Precision Medicine (PCMP) Accelerator Fund has divided $525,000 between eight promising personalized medicine projects addressing topics such as neurodegenerative diseases, infection control, cancer, and genetic variants....

PCORI to Spend $42M on Patient-Centered Comparative Research

by Jennifer Bresnick

The Patient-Centered Outcomes Research Institute (PCORI) is living up to its name by approving $42 million in funding to support 19 new studies focusing on comparing the effectiveness of different treatments for patient care. "We are pleased...

FDA Eager for Precision Medicine Under 21st Century Cures Act

by Jennifer Bresnick

The FDA is ready and willing to get started on the precision medicine and drug innovation opportunities created by the 21st Century Cures Act, FDA Commissioner Robert M. Califf, MD, said in a blog post. The legislation, signed into law by President...

Continue to site...